AI is reshaping global industries, but for smart healthcare startups, the biggest challenge remains how to translate technology into real-world clinical markets beyond isolated experiments. On December 18, the Taiwan Stock Exchange (TWSE) and international venture accelerator SparkLabs Taiwan co-hosted the Smart Health Capital Forum, bringing together representatives from medical startups, global pharmaceutical companies, and tech firms to share practical experiences in launching AI medical products and discuss balancing commercialization with clinical application.

China’s GPU start-ups are back at the center of a capital-market frenzy. Following Moore Threads, five-year-old MetaX has listed on Shanghai’s STAR Market, with its shares surging more than sevenfold on debut. At its peak, the company’s market capitalization briefly hit CNY330 billion (US$46.9 billion)—a striking number for a business generating just CNY1.5–2 billion in annual revenue, and one that would raise eyebrows even by global semiconductor standards.

As memory shortages and price increases extend through 2026, smartphone companies are considering downgrading memory capacities in their devices. Despite this, Jacob Chen, president of Samsung Taiwan’s Mobile Communications Division, stated that Samsung’s vertically integrated structure across the supply chain allows the company to benefit from memory shortages, supporting stronger smartphone sales. He expects Taiwan’s smartphone sales volume in 2026 to continue growing and confirmed that Samsung currently has no plans to reduce memory capacities in its devices.